Monday December 9, 2019

Viral hepatitis Caused 1.34 mn Deaths Globally: Study

Viral hepatitis was found to be amongst the top ten leading global killers

0
//
Viral hepatitis
World Health Organization poster for Hepatitis Campaign. VOA

London, Sep 16, 2017: Viral hepatitis with 1.34 million deaths globally has surpassed all chronic infectious diseases including HIV/AIDS, malaria and tuberculosis, according to a study by Global Burden of Disease.

The study reveals that in 2016, the total deaths caused by viral hepatitis, including liver cancer, acute cases, cirrhosis, hepatitis A, E, B, C and D account for 1.34 million globally, exceeding tuberculosis (1.2 million), HIV/AIDS (1 million) and malaria (719,000).

These staggering death rates occurred despite recent advances in hepatitis C medications that can cure most infections within three months and the availability of highly-effective vaccinations for hepatitis B.

“It’s outrageous, but not surprising, that the Global Burden of Disease Report found that deaths related to viral hepatitis have surpassed HIV, TB and malaria” said Charles Gore, President of the World Hepatitis Alliance — a not-for profit organisation based in London.

“This is largely due to a historic lack of political prioritisation coupled with an absent global funding mechanism,” Gore added, in the paper published in the journal the Lancet.

Further, viral hepatitis was found to be amongst the top ten leading global killers which include heart disease, road accidents, Alzheimer’s disease, amongst others.

Also Read: WHO Calls for stepped up action to Eliminate Hepatitis B and C by 2030 

If this trend has to be reversed, immediate action must be taken at both a regional and national level, said the report, while suggesting measures such as scaling up testing and diagnosis.

Viral hepatitis is a highly contagious liver infection caused by the hepatitis A virus and only 5 per cent of people living with the disease are aware of their conditions there are only few noticeable symptoms.

As a result, many people are either misdiagnosed or do not come forward for testing, increasing the chance of infecting others and missing the opportunity to access life-saving treatment.

Reducing hepatitis related deaths by 65 per cent by 2030 is a key component of the World Health Organization’s Global Hepatitis Strategy.

The strategy, which was adopted by 194 governments, sets out a list of key targets, which, if achieved, will eliminate viral hepatitis by 2030. (IANS)

 

Next Story

Start Checking Your Cholestrol Level from Mid-20s to Avoid Heart Disease: Study

Cholesterol is a fatty substance - a lipid - found in some foods and also produced in our liver

0
Heart
Researchers analysed the data obtained from almost four lakh persons in 19 countries and found a strong link between bad-cholesterol levels and risk of Heart disease from early adulthood over the next 40 years or more. Pixabay

A study has said that people should get their cholesterol levels checked from their mid-20s as the readings can be used to calculate lifetime risks of Heart disease and stroke.

The study, published in “The Lancet”, is the most comprehensive yet to look at the long-term health risks of having too much “bad” cholesterol for decades, the BBC reported.

Researchers maintain that earlier the people take action to reduce cholesterol through diet changes and medication, the better.

Cholesterol is a fatty substance – a lipid – found in some foods and also produced in our liver. It is needed to make hormones like oestrogen and testosterone, Vitamin D and other compounds.

While High-density lipoprotein (HDL) cholesterol is “good” as it keeps the body healthy, Low-density lipoprotein (LDL) is “bad” as it can clog arteries.

Researchers analysed the data obtained from almost four lakh persons in 19 countries and found a strong link between bad-cholesterol levels and risk of cardiovascular disease from early adulthood over the next 40 years or more.

They were able to estimate the probability of a heart attack or stroke for people aged 35 and over, according to their gender, bad-cholesterol level, age and risk factors such as smoking, diabetes, height and weight, and blood pressure.

The BBC quoted the report’s co-author Stefan Blankenberg of the University Heart Center in Hamburg: “The risk scores currently used in the clinic to decide whether a person should have lipid-lowering treatment only assess the risk of cardiovascular disease over 10 years and so may underestimate lifetime risk, particularly in young people.”

Heart
A study has said that people should get their cholesterol levels checked from their mid-20s as the readings can be used to calculate lifetime risks of Heart disease and stroke. Pixabay

Blankenberg told BBC: “I strongly recommend that young people know their cholesterol levels and make an informed decision about the result – and that could include taking a statin.”

However, he added, there is a danger that people could rely on statins rather than leading a health lifestyle and although they were usually well tolerated, studies had not been done on the potential side-effects of taking them over decades.

ALSO READ: Upcoming Apple iPhone May Have Qualcomm Ultrasonic Fingerprint Sensor

British Heart Foundation medical director Nilesh Samani said: “This large study again emphasises the importance of cholesterol as a major risk factor for heart attacks and strokes.

“It also shows that for some people, taking measures at a much earlier stage to lower cholesterol, for example by taking statins, may have a substantial benefit in reducing their lifelong risk from these diseases.” (IANS)